menu
    • menu

    Company profile for Rejuvenate Bio

    NEW Drugs in Dev: 1
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Rejuvenate Bio is a spinout from the Wyss Institute at Harvard focused on reversing aging and eliminating age-related disease. Rejuvenate Bio utilizes gene therapy, proprietary targets, and tools to bring treatments to patients suffering from age-related conditions. The company is developing a pipeline of therapies with applications in cardiac and metabolic disease.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Rejuvenate BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3560 Dunhill St, San Diego, CA 92121
    Telephone
    Telephone
    +1 858-381-3462
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.rejuvenatebio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/rejuvenate-bio/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/rejuvenatebio

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Rejuvenate Crowdfunds Gene Therapy for Aging Diseases
    Rejuvenate Crowdfunds Gene Therapy for Aging Diseases

    27 Apr 2026

    // BIOSPACE

    https://www.biospace.com/business/rejuvenate-crowdfunds-development-of-gene-therapy-for-aging-chronic-diseases

    BIOSPACE
    27 Apr 2026
    Share Share
    Rejuvenate Bio Announces Partial Reprogramming Extends Lifespan
    Rejuvenate Bio Announces Partial Reprogramming Extends Lifespan

    22 Feb 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240222406246/en

    BUSINESSWIRE
    22 Feb 2024
    Share Share
    Rejuvenate Bio Announces Partnership with Leading Animal Health Company
    Rejuvenate Bio Announces Partnership with Leading Animal Health Company

    14 Feb 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240214847283/en

    BUSINESSWIRE
    14 Feb 2024
    Share Share
    Rejuvenate Bio Announces Preclinical Data for Gene Therapy Candidate RJB-0402
    Rejuvenate Bio Announces Preclinical Data for Gene Therapy Candidate RJB-0402

    09 Oct 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231009006778/en

    BUSINESSWIRE
    09 Oct 2023
    Share Share
    Rejuvenate Bio shrinks staff
    Rejuvenate Bio shrinks staff

    12 Jun 2023

    // Kyle LaHucik ENDPTS

    https://endpts.com/rejuvenate-bio-shrinks-staff-pipeline-focus-as-george-church-spinout-eyes-2024-gene-therapy-ind/

    Kyle LaHucik ENDPTS
    12 Jun 2023
    Share Share
    Rejuvenate Bio Announces Data for Gene Therapy RJB-01
    Rejuvenate Bio Announces Data for Gene Therapy RJB-01

    18 May 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230518005611/en

    BUSINESSWIRE
    18 May 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search